Back to Results
First PageMeta Content
Ketones / Medicine / Navicular Disease / Drug rehabilitation / Amines / Organofluorides / Lysergic acid diethylamide / Dexamethasone / Methadone / Chemistry / Eli Lilly and Company / Organic chemistry


Date of Approval: April 28, 2014 FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA[removed]
Add to Reading List

Open Document

File Size: 194,72 KB

Share Result on Facebook

City

Overland Park / /

Company

B. Sponsor Dechra Ltd. / Johnson Research LLC / Dechra Ltd. / Susan L. Longhofer Dechra Ltd. / /

Country

Germany / /

Facility

College Boulevard / Laboratory Safety Study / /

IndustryTerm

treatment / injection site / study site / /

MedicalCondition

navicular syndrome / Hives/Pruritus / osteoarthritis / pain / local irritation / hives / primary soft tissue injury / /

Organization

Treatment Groups and Drug Administration / American Association of Equine Practitioners / Drug Administration / /

Person

David Kolb / Trent Staffordshire / Bradley King / Shaking / Robert Boswell / John Janicek / Stuart Shoemaker / /

Position

Investigator / General / Head / /

Product

Administration Intramuscular injection / dexamethasone / Sodium Chloride / OSPHOS Clodronate injection / C. Proprietary Name OSPHOS D. Established Name Clodronate injection / /

ProvinceOrState

Kansas / Idaho / /

Technology

pharmacokinetics / /

SocialTag